February 27, 2020 / 1:50 PM / a month ago

BRIEF-Sino Biopharmaceutical Unit's Drug Gets Approval For Drug Registration

Feb 27 (Reuters) - Sino Biopharmaceutical Ltd:

* BUDESONIDE SUSPENSION FOR INHALATION, A DRUG DEVELOPED BY UNIT OBTAINED APPROVAL FOR DRUG REGISTRATION GRANTED BY NMPA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below